Biotech Stock Buyback Helps Raise Prices
November 9, 2011
November 9, 2011 | Amgen spurs investors with a buyback program. The biotech planned to buy back $5 billion of its shares, about 10%, over the next month. As a result, stock prices jumped almost 6%. LA Times